Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Inventory Average (2022 - 2026)

bioAffinity Technologies has reported Inventory Average over the past 5 years, most recently at $65717.5 for Q1 2026.

  • Quarterly Inventory Average rose 97.97% to $65717.5 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $65717.5 through Mar 2026, up 97.97% year-over-year, with the annual reading at $40578.0 for FY2025, 76.07% up from the prior year.
  • Inventory Average was $65717.5 for Q1 2026 at bioAffinity Technologies, up from $44391.0 in the prior quarter.
  • Over five years, Inventory Average peaked at $65717.5 in Q1 2026 and troughed at $5627.5 in Q4 2022.
  • The 5-year median for Inventory Average is $23056.5 (2024), against an average of $25780.7.
  • Year-over-year, Inventory Average soared 175.53% in 2024 and then soared 43.67% in 2025.
  • A 5-year view of Inventory Average shows it stood at $5627.5 in 2022, then soared by 152.26% to $14196.0 in 2023, then skyrocketed by 86.57% to $26485.5 in 2024, then surged by 67.6% to $44391.0 in 2025, then skyrocketed by 48.04% to $65717.5 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Inventory Average are $65717.5 (Q1 2026), $44391.0 (Q4 2025), and $39602.5 (Q3 2025).